D-1626-2020 Class III Terminated
FDA drug recall D-1626-2020 was initiated by Legacy Pharmaceutical Packaging LLC on Sep 24, 2020 and is designated Class III. Reason for recall: Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles. The recall status is terminated (terminated Nov 8, 2022). Affected quantity: 111,948 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 7, 2020
- Initiation Date
- Sep 24, 2020
- Termination Date
- Nov 8, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 111,948 bottles
Product Description
Metformin Hydrochloride Tablets USP, 1000 mg, 60-count bottles, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc., East Brunswick, NJ 08816, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, Distributed by: Wal-Mart, Bentonville, AR 72716. NDC 68645-545-59
Reason for Recall
Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles.
Distribution Pattern
Walmart distribution centers in GA and AR
Code Information
Lot #: 201626, Exp. Date 08/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1626-2020
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026